These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5471845)

  • 1. Management of hypertension--further sodium and potassium studies.
    Priddle WW; Liu SF; Breithaupt DJ
    J Am Geriatr Soc; 1970 Nov; 18(11):861-92. PubMed ID: 5471845
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.
    Gordon RD; Geddes RA; Pawsey CG; O'Halloran MW
    Australas Ann Med; 1970 Nov; 19(4):287-94. PubMed ID: 5490655
    [No Abstract]   [Full Text] [Related]  

  • 3. Potassium-sparing effects of triamterene in the treatment of hypertension.
    Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF
    Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin activity, sodium and potassium in hypertensive patients.
    Overturf M; Fitz A; McBride J
    J Chronic Dis; 1972 Nov; 25(10):621-34. PubMed ID: 4647222
    [No Abstract]   [Full Text] [Related]  

  • 5. The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension.
    Oh MS; Carroll HJ
    Nephron; 1978; 21(5):269-76. PubMed ID: 714200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of an oral fluid load on the renal excretion of sodium in health and in hypertensive patients].
    Krück F; Krecke HJ; Knopp A
    Klin Wochenschr; 1966 Dec; 44(23):1349-55. PubMed ID: 5973249
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
    Weinberger MH; Dowdy AJ; Nokes GW; Luetscher JA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):359-71. PubMed ID: 5642688
    [No Abstract]   [Full Text] [Related]  

  • 8. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R; Struyvenberg A
    Eur J Clin Invest; 1978 Jun; 8(3):155-64. PubMed ID: 28952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hyperuricemia by allopurinol in hypertensive patients treated with chlorothiazide.
    Nicotero JA; Scheib ET; Martinez R; Rodnan GP; Shapiro AP
    N Engl J Med; 1970 Jan; 282(3):133-5. PubMed ID: 4902227
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of some indices of mineral metabolism in hypertensive patients under conditions of diet therapy].
    Trangeĭzer VA
    Vopr Pitan; 1966; 25(3):29-34. PubMed ID: 6003572
    [No Abstract]   [Full Text] [Related]  

  • 12. Diuretic and diet treatment of hypertension.
    Dustan HR; Tarazi RC; Bravo EL
    Arch Intern Med; 1974 Jun; 133(6):1007-13. PubMed ID: 4829750
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of hydrochlorothiazide in hypertensive patients and the need for potassium supplementation.
    Kochar MS; Itskovitz HD
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):298-304. PubMed ID: 4197254
    [No Abstract]   [Full Text] [Related]  

  • 14. The comparative effect of chlorothiazide and meralluride on the development of hepatic encephalopathy in cirrhotic patients.
    Weisberg H; Strobos RJ; Rosenthal WS; Appleton HD; Glass GB
    Gastroenterologia; 1966; 105(6):321-34. PubMed ID: 5958596
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypokalemia in experimental renovascular hypertension.
    Fujii J; Yazaki Y
    Tohoku J Exp Med; 1971 Aug; 104(4):331-4. PubMed ID: 5124680
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic and hypotensive effects of ethacrynic acid. Comparative study with hydrochlorothiazide.
    Russell RP; Lindeman RD; Prescott LF
    JAMA; 1968 Jul; 205(1):81-5. PubMed ID: 5694972
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of plasma renin concentration following acute natriuresis and orthostasis in healthy subjects and patients suffering from hypertension].
    Oelkers W; Magnus R; Samwer KF
    Klin Wochenschr; 1970 May; 48(10):598-607. PubMed ID: 5517328
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiloride. A potassium-sparing natriuretic agent.
    Bull MB; Laragh JH
    Circulation; 1968 Jan; 37(1):45-53. PubMed ID: 5634728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Namestin (Clonidine), 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in the treatment of essential hypertension (author's transl)].
    Lageder H; Hartl O; Irsigler K
    Wien Klin Wochenschr; 1974 Oct; 86(19):561-3. PubMed ID: 4611047
    [No Abstract]   [Full Text] [Related]  

  • 20. Potassium loss associated with hydrochlorothiazide versus chlorthalidone.
    Sumiye L; Vivian AS; Frisof KB; Podany EC
    Clin Ther; 1981; 4(4):308-20. PubMed ID: 7332917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.